Sort

Search

01/03/2026 Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer
Uleri, A, Baboudjian, M, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Dariane, C, Baud, H, Olivier, J, Rios, AR, Sanguedolce, F, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer. PROSTATE CANCER AND PROSTATIC DISEASES. 2026; 29(1)DOI:10.1038/s41391-025-00977-6. PMID:40301553. IF:5.800(Q1/1D).
01/03/2026 International Delphi consensus on UTUC management: The IMPACT UTUC project
Pandolfo, SD, Contieri, R, Catto, J, Briganti, A, Roupret, M, Pradere, B, Porpiglia, F, Amparore, D, Minervini, A, Bertolo, R, Moschini, M, Mertens, L, Rhijn, BWGV, Gallioli, A, Formisano, L, Imbimbo, C, Lucarelli, G, Ferro, M, Gupta, S, Mir, MC, Derweesh,, Djaladat, H, Bukavina, L, Autorino, R. International Delphi consensus on UTUC management: The IMPACT UTUC project. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026 A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders
Bolsewig, K, Bellomo, G, Hok-A-Hin, YS, Al Idrissi, I, Vermunt, L, Lleó, A, Alcolea, D, Sieben, A, Engelborghs, S, Simonsen, AH, Hasselbalch, SG, Bech, S, Morrema, THJ, Hoozemans, JJM, Bol, JGJM, Van Alphen, J, Gaetani, L, Chiasserini, D, Paoletti, FP, Parnetti, L, Kang, SW, Lee, YG, Jeon, S, Lee, AH, Jeon, S, Ye, BS, Milán, MD, Van Der Flier, WM, Van De Berg, WDJ, Lemstra, AW, Willemse, EAJ, Teunissen, CE. A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. NATURE MEDICINE. 2026; 32(3)DOI:10.1038/s41591-026-04212-0. PMID:41699128. IF:50.000(Q1/1D).
01/03/2026 Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis
Fairweather, M, Sulciner, M, Jolissaint, JS, Fiore, M, Ortega, DYG, Iwata, S, Ford, SJ, Swallow, C, Nizri, E, Quagliuolo, V, Nessim, C, Adamkova, D, Rutkowski, P, Cardona, K, Kim, E, Porpiglia, AS, Johnston, FM, Gyorki, DE, Vincenzi, B, Corina, KF, Kramer, S, Blazer, D, Tseng, WW, Albertsmeier, M, González, JA, Hompes, D, Baldini, EH, Gronchi, A, Rauta, CP. Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103805. PMID:41783086. IF:10.000(Q1/1D).
01/03/2026 [Translated article] Guidelines on the perioperative management of chronic medication in surgical patients
Carbó, LVV, Gómez, MJE, Gómez, IRJ, Sánchez, AR, Oliveros, NV, Gil, ABG, Villegas, AC, Campillos, P, Martinez, PO, de Pourcq, JT. [Translated article] Guidelines on the perioperative management of chronic medication in surgical patients. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.11.002. PMID:41372088. IF:(Q/D).
01/03/2026 [Translated article] Risk stratification tool for pharmaceutical care in patients with cardiovascular disease
Lopez, AD, Escrig, EV, Serrano, PS, Morillo-Verdugo, R. [Translated article] Risk stratification tool for pharmaceutical care in patients with cardiovascular disease. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.11.001. PMID:41387041. IF:(Q/D).